Keywords: Ipsen, Dysport, US launch, Taspoglutide, Research, Roche,

Ipsen launch’s Dysport in USA, updates on taspoglutide

Article | 29 October 2009

Print This

French specialty pharmaceutical group says that its drug Dysport (abobotulinumtoxinA for Injection) is now available in the USA for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in